Clinical Trials Browser

OTHER × Amyloidosis × belantamab mafodotin × Clear all

NCT05145816 2026-05-07

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis